Literature DB >> 9351570

Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma.

C L Kempton1, P J Kurtin, D J Inwards, P Wollan, D G Bostwick.   

Abstract

Patients with malignant lymphoma of the bladder were studied, and three clinical groups were defined: those with primary lymphoma localized in the bladder, lymphoma presenting in the bladder as the first sign of disseminated disease (nonlocalized lymphoma), and recurrent bladder involvement by lymphoma in patients with a history of malignant lymphoma (secondary lymphoma). The differences in these groups regarding lymphoma type, clinical presentation, and clinical outcome were studied. Mayo Clinic Tissue Registry records from 1940 to 1996 were searched to identify patients with lymphomas involving the bladder. The lymphomas were classified based on review of the histology and immunophenotype performed by immunoperoxidase methods. Clinical records were reviewed. Presenting symptoms included urinary frequency, dysuria, hematuria, and lower abdominal and back pain. Primary lymphoma was present in six patients. All were B-cell lineage low-grade lymphomas of the mucosa-associated lymphoid tissue (MALT) type. No patient had recurrent lymphoma or died of lymphoma. Nonlocalized bladder lymphoma occurred in 17 patients; one with low-grade lymphoma of the MALT type, four with follicle center lymphomas, and 12 with large cell lymphomas. Excluding two patients who died postoperatively, median survival was 9 years. Six patients died of lymphoma in the follow-up period. Secondary bladder lymphoma occurred in 13 patients: two with low-grade lymphoma of the MALT type, one with follicle center lymphoma, one with mantle cell lymphoma, and nine with diffuse large cell lymphomas. Median survival in this group was 0.6 years. Low-grade lymphoma of the MALT type was the most frequent type of primary bladder lymphoma and was associated with an excellent prognosis. The bladder can be the presenting site of lymphomatous involvement in patients with more widespread disease. Survival in this group is quite favorable and is presumably dependent on lymphoma histologic type, stage of disease, and other prognostic factors. Bladder involvement by recurrent lymphoma is a sign of widely disseminated disease and is associated with a very poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351570     DOI: 10.1097/00000478-199711000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  22 in total

1.  Twenty-year Experience with Genitourinary Lymphoma at a Community Hospital.

Authors:  Yazhini Vallatharasu; Adithya Chennamadhavuni; Marvin J Van Every
Journal:  Clin Med Res       Date:  2021-03-31

2.  Primary Urinary Tract Lymphoma: Rare but Aggressive.

Authors:  Konstantinos Lontos; Anastasia Tsagianni; Pavlos Msaouel; Leonard Joseph Appleman; Dimitrios Nasioudis
Journal:  Anticancer Res       Date:  2017-12       Impact factor: 2.480

3.  Malignant lymphoma occurring simultaneously in the urinary bladder wall and bilateral renal parenchyma: A case report.

Authors:  Jie Min; Hao Geng; Dexin Yu; Tao Zhang; Zhiqiang Zhang
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

4.  Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases.

Authors:  A W Bates; A J Norton; S I Baithun
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

5.  Primary lymphoma of the bladder: a report of three cases.

Authors:  R E Power; E W Kay; F O'Connell; A A Jaber; M G Donovan; D P Hickey; T A Creagh
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

6.  Extranodal marginal zone B cell lymphoma of MALT type involving the mucosa of both the urinary bladder and stomach.

Authors:  S M Kröber; C Aepinus; P Ruck; H-K Müller-Hermelink; H-P Horny; E Kaiserling
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

7.  Concurrent bladder lymphoma and bladder cancer presenting as metastatic bladder cancer.

Authors:  Jae Heon Kim; Ji Sung Shim; Tae Il Noh; Hong Jae Ahn; Jae Hyun Bae; Jae Young Park
Journal:  World J Mens Health       Date:  2012-08-31       Impact factor: 5.400

8.  Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.

Authors:  Olga K Weinberg; Lisa Ma; Katie Seo; Andrew H Beck; Reetesh K Pai; Anjali Morales; Youn Kim; Uma Sundram; Daryl Tan; Sandra J Horning; Richard T Hoppe; Yasodha Natkunam; Daniel A Arber
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

9.  Primary non-hodgkin lymphoma of urinary bladder with nine years later renal involvement and absence of systemic lymphoma: a case report.

Authors:  Tatjana Terzic; Sanja Radojevic; Vesna Cemerikic-Martinovic; Radmila Stevanovic; Sanja Citlucanin; Dragan Mitrovic; Biljana Stojimirovic; Jasmina Markovic-Lipkovski
Journal:  Med Oncol       Date:  2007-11-27       Impact factor: 3.064

10.  "An Unusual Urological Tumour": Above the Collar and below the Belt.

Authors:  Erik K Mayer; Shabnam Undre; Daniel C Cohen; Marjorie M Walker; Justin A Vale; Anup Patel
Journal:  Case Rep Oncol Med       Date:  2012-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.